Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma
Lejla Mutapcic Vajzovic1, Timothy G Murray1, Mohammad A Aziz-Sultan2, Amy C Schefler1, Stacey Quintero Wolfe2, Ditte Hess1, Cristina E Fernandes3, Sander R Dubovy1,41Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 2Department of Neurological Surgery, Unive...
Guardado en:
Autores principales: | Lejla Mutapcic Vajzovic, Timothy G Murray, Mohammad A Aziz-Sultan, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8ba80794d1c4170872b0e2b406de1eb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding
por: Kim JW, et al.
Publicado: (2011) -
Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
por: Samuel K Houston, et al.
Publicado: (2011) -
Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution
por: Thampi S, et al.
Publicado: (2013) -
Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy
por: Aziz HA, et al.
Publicado: (2012) -
Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors
por: Y Piña, et al.
Publicado: (2011)